NASDAQ: ABOS - Acumen Pharmaceuticals, Inc.

Yield per half year: -62.63%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Acumen Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc., биофармацевтическая компания клинической стадии, занимается разработкой терапевтических средств для лечения болезни Альцгеймера и других нейродегенеративных заболеваний. Компания сосредоточена на продвижении препарата-кандидата для таргетной иммунотерапии ACU193, который находится на клинической стадии фазы I для нацеливания на растворимые олигомеры бета-амилоида. Компания Acumen Pharmaceuticals, Inc. была зарегистрирована в 1996 году и базируется в Шарлоттсвилле, штат Вирджиния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-07-01
ISIN US00509G2093
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://acumenpharm.com
Цена ао 1.19
Change price per day: -1.82% (1.1)
Change price per week: +19.87% (0.901)
Change price per month: -6.9% (1.16)
Change price per 3 month: -34.55% (1.65)
Change price per half year: -62.63% (2.89)
Change price per year: -65.93% (3.17)
Change price per 3 year: -67.37% (3.31)
Change price per year to date: -37.21% (1.72)
All parameters

Underestimation

Title Value Grade
P/S 703.62 1
P/BV 0.6737 10
P/E 4.4 10
EV/EBITDA -2.32 0
Total: 5.13

Efficiency

Title Value Grade
ROA, % -16.89 0
ROE, % -19.62 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4627 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % -30 0
Yield Ebitda, % 552.66 10
Yield EPS, % 299.03 10
Total: 8
More

Institutions Volume Share, %
Alyeska Investment Group, L.P. 940 1.56
Sands Capital Ventures, LLC 3 5.69
Franklin Resources, Inc. 3 5.65
Millennium Management LLC 3 4.38
Rock Springs Capital Management, LP 2 3.83
FMR, LLC 2 3.48
Laurion Capital Management, LP 2 3.15
Vanguard Group Inc 2 2.77
Knollwood Investment Advisory, LLC 2 2.71
Price (T.Rowe) Associates Inc 1 1.83



Head Job title Payment Year of birth
Mr. Matt Zuga CFO & Chief Business Officer 608.29k
Mr. Russell Barton M.S. Chief Operating Officer 223.68k 1959 (66 years)
Mr. Derek M. Meisner Esq., J.D. Chief Legal Officer & Corporate Secretary 240.17k 1971 (54 years)
Ms. Alex Braun M.B.A. VP & Head of Investor Relations N/A
Dr. Grant A. Krafft Ph.D. Co-Founder 42k
Dr. Caleb E. Finch Ph.D. Co-Founder N/A
Dr. William L. Klein Ph.D. Co-Founder N/A
Ms. Kelly Carranza Vice President, Finance & Accounting and Corporate Controller N/A
Dr. James Doherty Ph.D. President & Chief Development Officer N/A 1968 (57 years)
Mr. Daniel J. O'Connell M.B.A. CEO & Director 1970 (55 years)

Address: United States, Charlottesville. VA, 427 Park Street - open in Google maps, open in Yandex maps
Website: https://acumenpharm.com